The invention relates to a personalized medical device intended for correction of defects, in particular in the orofacial area, and to a method of its preparation, and belongs to the field of healthcare.
The biological functionality of an adequately prenatally developed hard and soft palate ensures the normal development of the respiratory and suction reflex as well as the related normal alimony ability and auditory conformity immediately postnatally in a human individual. In the late period of infancy, or in the period of the toddler, in the case of a palate unaffected by cleft, the normal development of speech, phonetics with the correct development of auditory perception of speech is ensured. In the period of preschool and school age, this ensures the normal psychomotor and psychosocial development of such a child. Said important functions can be significantly limited postnatally to varying degrees in the embryonic or prenatal phase of abnormal development of hard or soft palate, when they are affected by different types of cleft of hard or soft palate.
In the case of congenital clefts of orophation with an intervention in the area of the maxillary alveolar arch and in the hard palate area is nowadays applied postnatally in pre-surgical correction (PSO) (based on the impression-imprint technique modified according to Figuero and Grayson) produced by the so-called active temporary modulation device based on WHO recommendations: Global strategies to reduce the health-care burden of craniofacial anomalies of year 2002 and AAPD and ACPA: Policy on the Management of Patients with Cleft Lip/Palate and Other Craniofacial Anomalies of year 2012. According to available studies, pre-surgical correction (PSO) and so-called presurgical nasoalveolar molding (PNAM) undoubtedly has several advantages, such as:
Current pre-surgical correction (PSO) and the so-called presurgical nasoalveolar molding (PNAM) also has several negative effects:
Similarly, other congenital malformations can thus damage a person's further biological, psychological and social development in the early as well as later child's postnatal phase of a person's life. As we can currently identify almost 98% of structural congenital developmental abnormalities using imaging methods (USG, MRI, CT), we now need to establish a system for the prenatal process and a method for creating individualized custom-made medical devices, replacements and implants made by the “additive manufacturing” system. Personalized inserts from additive manufacturing fully correlate and take into account the anatomy of the selected individual and solve problems associated with the responses of the patient's body to non-personalized products and components and the late time frame of their application due to the length of postnatal error description and postnatal production.
In the long run, i.e. over a period of 20 years, in the field of temporary neonatal palate replacements, form of imprint production of a single-composite palate temporary replacement based on vinylpolysiloxanes or light polymerizing acrylates is mainly used. However, these types of replacements bring with them unavoidable limits in terms of the replacement of the hard palate absent due to cleft, namely in the effectiveness of sealing faulty communications with the nasal cavity, the absent part of the soft palate replacement during alimentation and last but not least vector mechanics in the area of displacement of interest in the process of maxillary orthopaedic-anatomical correction. The impact of the ineffectiveness of these temporary replacements on the affected individual in the first days to weeks of the neonatal age stage brings fatal consequences to his further plastic-corrective management, speech therapy articulation development, psychological affectation, educational process and social-work classification. Also, the attachment of these replacements brings significant discomfort for the facial part of the individual and the associated ineffective cooperation between doctor-patient and doctor-parent.
The current state in the field of pre-surgical correction of cleft maxillary alveolar arch defects, premaxil and palate is the choice of production of single-composite impression implants in the time horizon of about 1 to 12 weeks from the birth of a newborn. Pre-surgical correction is based on the classification description Kernahan's striped Y logo (year 1971): Block 1 and 4: lip, Block 2 and 5: alveolar arch, Block 3 and 6: anterior hard palate after incisive foramen, Block 7 and 8: posterior hard palate after posterior nasal spine, Block 9: soft palate, or from a modified Kernahan's classification developed by the American Cleft Association (Harkins et al., 1982): Prepalatal clefts (lip, alveolar arch, unilateral, central, bilateral), Palatal clefts (hard and soft palate), Prepalatal and palatal clefts (combinations).
Based on these classifications, a specific, although limited, algorithm is developed in the further postnatal management of such an affected individual. Until now, routine practice has applied time procedures in the care of individuals affected by cleft orophation based only on a postnatal algorithm developed in the second half of the twentieth century by specialists from the Children's Hospital of Philadelphia (year 1971).
The analysis of the current state in the field of production of temporary medical surgical devices for cleft management of orophation is based only on the postnatal period, as the whole algorithm of clinical steps currently applies only to this period. The current postnatal production of orofacial temporary cleft replacements is based on two aspects of presurgical nasoalveolar molding (PNAM) production.
The above production of postnatal pre-surgical orofacial devices is also based on the following patent solutions RU2369347C1, US 2011/0060438 A1, RU94450U1, US 2015/0164676 A1, U.S. Pat No. 8,323,308B2, CN101673481A, RU2593235C1 and scientific articles:
Bauer, F., Schönberger, M., Gattinger, J., et al. (2017). RapidNAM: generative manufacturing approach of nasoalveolar molding devices for presurgical cleft lip and palate treatment. Biomedical Engineering/Biomedizinische Technik, 62 (4), pp. 407-414. Retrieved 18 May 2018, from doi:10.1515/bmt-2016-0035;
Loeffelbein D. J., Rau A., Wolff K.-D.: Impression technique for monitoring and virtual treatment planning in nasoalveolar moulding: British Journal of Oral and Maxillofacial Surgery (2013), 51 (8), pp. 898-901;
Quan, Y, Gong, X., Guo-Min, W. et al.: A Novel Technique for Presurgical Nasoalveolar Molding Using Computer-Aided Reverse Engineering and Rapid Prototyping: Journal of Craniofacial Surgery January (2011), 22 (1), pp. 142-146;
Ritschl, L. M., et al.: Pitfalls and solutions in virtual design of nasoalveolar molding plates by using CAD/CAM technology—A preliminary clinical study: J Craniomaxillofac Surg. (2016), 44 (4), pp. 453-459.
The personalized medical device and the method of its preparation according to present invention, in particular the orofacial personalized medical device in the PNAM process bring a significant advance in the creation and production of medical devices, in particular for clefts of the face and palate by a system of their individualization for individuals with the intervention of creating a replacement of hard and soft palate even in prenatal period using CT, MRI and 3D/4D electronic USG imaging and 3D printing additive production technology.
The personalized medical device intended for correction of defects, in particular in the orofacial area, is multicomposite and comprises a hard tissue replacement and a soft tissue replacement. The hard tissue replacement is a hard core of biocompatible thermoplastic material and the soft tissue replacement is a biocompatible elastic substance. The medical device may be implantable as well as non-implantable.
The biocompatible thermoplastic material for the non-implantable device may be from the group of hardened silicone, methacrylate-based substances, polypropylene sulfone.
The biocompatible thermoplastic material for the implantable device may be a synthetic osseointegratable bioresorbable material or a synthetic osseointegratable non-resorbable material.
The synthetic osseointegratable bioresorbable material may be polycaprolactone and the synthetic osseointegratable non-resorbable material may be polyaryl ketones or polyaryl ketones in combination with ceramics or polyaryl ketones in combination with ceramics and with reinforcement. The reinforcement can be made of carbon and/or glass fibres.
The biocompatible elastic substance for the non-implantable device may be based on elastic silicone or polyurethane and for the implantable device may be an epithelial colony of a corrected defect.
It is advantageous if the surface treatment of the hard core of biocompatible thermoplastic material is adapted to attach even the soft tissue of the cleft. The surface treatment of the hard core can be solved by coating or dipping.
It is advantageous if the shape of the personalized medical device is adapted to attach to an alveolar arch.
The process of production a personalized medical device according to this invention is unique, as evidenced by the complete worldwide literature absence for the creation of such replacements by said innovative and modern process. In any case, attempts at centralized production of medical devices in form of 3D printing of medical devices from 3D/4D fetal sonography have already been reported for 2016 in scientific peer-reviewed journals for ultrasound gynecological and obstetric specialists. However, these articles provide only a look at 3D prints as academic tools for modelling the fidelity of structures, such as placental pathologies, facial dysmorphia, limb abnormalities, fetal heart anatomy, and their plastic models for graduate education. However, so far with virtually no benefit for the direct clinical therapeutic solution of the patient.
The process of clinical defect management based on prenatal additive manufacturing of the individualized PNAM device changes the postnatal management so far in the first three phases to the prenatal-fetal period.
The nature and uniqueness of the invention is based on prenatal production in form of additive manufacturing of the multicomposite pre-surgical device PNAM personalized to measure with the possibility for its immediate postnatal applicability to the newborn. Prenatal production and individualization of such devices for an individual depends on the quality of DICOM data collection from a properly timed prenatal implementation of 3D/4D mechanical and digital USG visualization of cleft of fetal orophation. 3D USG visualization and its optimization consists of several steps:
It is advantageous to surface-treat the hard tissue replacement. This can be done by coating or dipping.
Prior to producing a clinically applicable model of the personalized medical device, is appropriate to additively produce a reference model of the deformity itself as well as a medical device model, wherein there are validated dimensions on the reference models and are considered by consultation in terms of fixation and application parameters.
The disadvantages of the present solutions are overcome by the features of the present invention. The advantages achieved by the multicomposite personalized medical device intended for correction of defects, in particular in the orofacial area according to this invention, are as follows:
This invention has been prepared with the support of the following grants: APVV-17-0278, APVV-15-0111, APVV-15-0356, VEGA 1/0179/19, Incentives for Research and Development, no. of agreement 1223/2018.
A personalized medical device according to this invention intended for correction of defects in the orofacial area is prepared. It is multicomposite and comprises a hard tissue replacement and a soft tissue replacement. The hard tissue replacement is a hard core of biocompatible thermoplastic material and the soft tissue replacement is a biocompatible elastic substance. The medical device is non-implantable.
A biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment is hardened silicone.
A biocompatible elastic material used as a soft tissue replacement in this example of embodiment is elastic silicone.
The surface treatment of the hard core of hardened silicone is adapted to attach even the cleft-affected soft tissue. In this example of embodiment, the surface treatment is solved by coating.
The shape of the personalized medical device is adapted to attach to an alveolar arch.
A method for preparation of the personalized medical device according to this example of embodiment comprises the following steps:
The preparation of a personalized medical device takes place in the prenatal period and postnatal period. The prenatally prepared device can be immediately administered postnatally to the newborn.
Prior to producing a clinically applicable model of the personalized medical device, a reference model of the deformity itself as well as a medical device model is additively produced, wherein there are validated dimensions on the reference models and are considered by consultation in terms of fixation and application parameters.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment is polymethyl methacrylate and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is elastic silicone.
In this example of embodiment, the surface treatment of the hard tissue is solved by dipping.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment is polymethyl methacrylate and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is polyurethane.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment is polypropylene sulfone and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is elastic silicone.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment is polypropylene sulfone and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is polyurethane.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that it is an implantable medical device and a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment is bioresorbable, osseointegratable polycaprolactone and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is epithelial colony replacing the mucosa of the soft palate.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that it is an implantable medical device and a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment are non-resorbable, osseointegratable polyaryl ketones and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is epithelial colony replacing the mucosa of the soft palate.
The personalized medical device and method of its preparation according to this example of embodiment are identical to Example 1, except that it is an implantable medical device and a biocompatible thermoplastic material used as a hard tissue replacement in this example of embodiment are non-resorbable, osseointegratable polyaryl ketones in combination with ceramics and a biocompatible elastic substance used as a soft tissue replacement in this example of embodiment is epithelial colony replacing the mucosa of the soft palate.
The industrial applicability of the invention is obvious. The personalized medical device according to this invention is intended in particular for correction of defects in the orofacial area and for its preparation in the prenatal period as well as in the postnatal period. However, the use of the invention is also possible for the production of personalized medical devices as a replacement for other parts of the human body.
Number | Date | Country | Kind |
---|---|---|---|
PP 8-2020 | Feb 2020 | SK | national |
PUV 17-2020 | Feb 2020 | SK | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/SK2021/050002 | 2/12/2021 | WO |